Development of novel treatment strategies targeting the R-spondin-LGR-APC axis in glioblastoma stem cells
Project/Area Number |
15K06838
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Tumor biology
|
Research Institution | Chiba University (2016-2017) Tokai University (2015) |
Principal Investigator |
NASU Ryo 千葉大学, 大学院医学研究院, 特任助教 (30466859)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | がん / がん幹細胞 / 膠芽腫 / Wntシグナル / がん免疫 / 癌 / 癌幹細胞 / LGR5 / APC / Axin1 / 腫瘍免疫 |
Outline of Final Research Achievements |
Glioblastoma is the most common and aggressive malignant brain tumor in adults. In this study, we tried to develop a new therapy that targets the interaction of glioblastoma stem cells with their specific microenvironments. We found a crucial role of the R-spondin-LGR5-APC axis in the control of Wnt signaling in glioblastoma stem cells. Moreover, R-spondin/Wnt stimuli activate Wnt signaling via promoting the phosphorylation of Axin1 at T160. Thus, small molecules that inhibit Axin1 T160 phosphorylation hold promise as novel anti-tumor reagents.
|
Report
(4 results)
Research Products
(12 results)
-
-
[Journal Article] Imbalanced expression of polycistronic miRNA in acute myeloid leukemia.2017
Author(s)
Kotaki R, Higuchi H, Ogiya D, Katahira Y, Kurosaki N, Yukihira N, Ogata J, Yamamoto H, Mohamad Alba S, Azhim A, Kitajima T, Inoue S, Morishita K, Ono K, Koyama-Nasu R, Kotani A.
-
Journal Title
Int J Hematol.
Volume: 106
Issue: 6
Pages: 811-819
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
-
-
-